Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Risk funding for radical new blood test

12.01.2006


NESTA (the National Endowment for Science, Technology and the Arts) announces today an investment round worth £500,000 to commercialise an innovative new monitoring device which samples blood while it is still within the patient’s body.



Blood analysis is costly and labour-intensive. It relies almost exclusively on blood withdrawal and off-line analysis, requiring extensive input from professional health staff – which inevitably leads to delays and can result in errors.

The new funding for Bedford-based Probe Scientific is from NESTA and the co-investors are Acorn Services Group and private investors.


Many hospital patients already have an intravenous catheter, usually in the back of the hand or lower arm. This catheter enables medical staff to give fluids and take blood samples simultaneously. But for much of the time, the catheters are capped, awaiting use.

Probe Scientific has developed MicroEYE, which is designed to sit inside the catheter and sample the patient’s blood, without removing it from the body.

It relies on a semi-permeable membrane being in contact with a patient’s biological fluid and, by dialysis, extracting certain key indicator molecules from the fluid for continuous analysis at the bedside.

Mark White, Director of Invention & Innovation at NESTA, said:

"Probe Scientific is a great example of the kind of UK innovation our early stage seed funding is designed to support. Through investing in its innovative MicroEYE technology we are looking to ensure that this idea has every opportunity of being fully commercialised, benefiting patients and the UK economy."

The investment coincides with the appointment of Neil Smith as CEO, joining founder Dr Mark O’Connell from the University of Cambridge. The board of Probe Scientific has also been further strengthened by the appointment of Paul Jenkinson as CFO and Mike Sundler as non-executive director.

Joseph Meaney | alfa
Further information:
http://www.nesta.org.uk/mediaroom/newsreleases/

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

IVAM’s LaserForum visits the Swiss canton of St. Gallen with the topic ultrashort pulse lasers

06.09.2017 | Event News

 
Latest News

Robust and functional – surface finishing by suspension spraying

19.09.2017 | Materials Sciences

The Wadden Sea and the Elbe Studied with Zeppelin, Drones and Research Ships

19.09.2017 | Earth Sciences

Digging sensors out of an efficiency hole

19.09.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>